Compare FPH & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FPH | NAUT |
|---|---|---|
| Founded | 2009 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 300.7M | 347.7M |
| IPO Year | 2013 | 2020 |
| Metric | FPH | NAUT |
|---|---|---|
| Price | $4.48 | $2.32 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 283.5K | ★ 8.2M |
| Earning Date | 10-22-2026 | 10-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 16.07 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $110,020,000.00 | N/A |
| Revenue This Year | $1,459.63 | N/A |
| Revenue Next Year | $5.38 | $708.84 |
| P/E Ratio | $11.40 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.02 | $0.84 |
| 52 Week High | $6.47 | $4.31 |
| Indicator | FPH | NAUT |
|---|---|---|
| Relative Strength Index (RSI) | 52.50 | 50.98 |
| Support Level | $4.11 | $2.21 |
| Resistance Level | $4.64 | $2.46 |
| Average True Range (ATR) | 0.17 | 0.33 |
| MACD | 0.05 | -0.08 |
| Stochastic Oscillator | 70.27 | 23.08 |
Five Point Holdings LLC is an owner and developer of mixed-use, master-planned communities in California. It is engaged in developing new communities that, in addition to homesites, include commercial, retail, educational, and recreational elements, as well as civic areas, parks, and open spaces. Its four reportable segments are Valencia, San Francisco, Great Park, and Hearthstone. It derives the majority of revenue from the Great Park segment, which includes Great Park Neighborhoods being developed adjacent to and around the Orange County Great Park, a metropolitan park under construction in Orange County, California.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.